344 results on '"Gendler, Sandra J."'
Search Results
2. Supplementary Figures 1 and 2 from Downregulation of Hematopoietic MUC1 during Experimental Colitis Increases Tumor-Promoting Myeloid-Derived Suppressor Cells
3. Supplementary Figure Legends from Downregulation of Hematopoietic MUC1 during Experimental Colitis Increases Tumor-Promoting Myeloid-Derived Suppressor Cells
4. Supplementary Figure 2 from Lack of Muc1-Regulated β-Catenin Stability Results in Aberrant Expansion of CD11b+Gr1+ Myeloid-Derived Suppressor Cells from the Bone Marrow
5. Supplementary Figure S2 from Inhibition of Adaptive Immunity by IL9 Can Be Disrupted to Achieve Rapid T-cell Sensitization and Rejection of Progressive Tumor Challenges
6. Data from Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis
7. Supplementary Figure Legends 1-3 from Lack of Muc1-Regulated β-Catenin Stability Results in Aberrant Expansion of CD11b+Gr1+ Myeloid-Derived Suppressor Cells from the Bone Marrow
8. Data from Inhibition of Adaptive Immunity by IL9 Can Be Disrupted to Achieve Rapid T-cell Sensitization and Rejection of Progressive Tumor Challenges
9. Data from Lack of Muc1-Regulated β-Catenin Stability Results in Aberrant Expansion of CD11b+Gr1+ Myeloid-Derived Suppressor Cells from the Bone Marrow
10. Supplementary Figure 1 from Lack of Muc1-Regulated β-Catenin Stability Results in Aberrant Expansion of CD11b+Gr1+ Myeloid-Derived Suppressor Cells from the Bone Marrow
11. Supplementary Figure Legend from Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis
12. Supplementary Figure 1 from Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis
13. Supplementary Figure Legends from Inhibition of Adaptive Immunity by IL9 Can Be Disrupted to Achieve Rapid T-cell Sensitization and Rejection of Progressive Tumor Challenges
14. Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells
15. Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
16. Airway Mucin Genes and Gene Products
17. Characterization and Evolution of an Expressed Hypervariable Gene for a Tumor-Associated Mucin, MUC-1
18. Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma
19. Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity
20. Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model
21. The gastric mucus layers: constituents and regulation of accumulation
22. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection
23. Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas
24. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis
25. Increased levels of mucins in the cystic fibrosis mouse small intestine, and modulator effects of the Muc1 mucin expression
26. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation
27. Reduced T-Cell and Dendritic Cell Function Is Related to Cyclooxygenase-2 Overexpression and Prostaglandin E2 Secretion in Patients With Breast Cancer
28. Downregulation of Muc1 in MMTV-c-Neu tumors
29. MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion
30. Lack of the intestinal Muc1 mucin impairs cholesterol uptake and absorption but not fatty acid uptake in Muc[1.sup.-/-] mice
31. Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model
32. Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice
33. MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment
34. MUC1, The Renaissance Molecule
35. Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression
36. MUC1 Mucin Is a Negative Regulator of Toll-Like Receptor Signaling
37. Molecular characterization of the large heavily glycosylated domain glycopeptide from the rat small intestinal Muc2 mucin
38. Regulation of Mucin Genes in Chronic Inflammatory Airway Diseases
39. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis
40. Tumor-associated carbohydrate antigens: A possible avenue for cancer prevention
41. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells
42. Letter for Joyce
43. Influence of organ site and tumor cell type on MUC1-specific tumor immunity
44. Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide
45. Cystic Fibrosis Mice Lacking Muc1 Have Reduced Amounts Of Intestinal Mucus
46. Dendritic Cell–Tumor Cell Fusion and Staphylococcal Enterotoxin B Treatment in a Pancreatic Tumor Model
47. Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide
48. Vaccination with Allogeneic Dendritic Cells Fused to Carcinoma Cells Induces Antitumor Immunity in MUC1 Transgenic Mice
49. Immunotherapeutic Strategies in Breast Cancer:Preclinical and Clinical Trials
50. Spontaneous adenocarcinoma mouse models for immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.